Netherlands· NL-1ef8a5fd1930
Telmisartan/Hydrochloorthiazide Sandoz 80/12,5 mg, omhulde tabletten
A telmisartan und diuretika product containing hydrochloorthiazide + telmisartan, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Telmisartan und diuretika is registered in 13 of 19 countries.
Countries holding a registration under ATC C09DA07 (telmisartan und diuretika), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 9 of them publish a price we can compare per daily dose
Telmisartan und diuretika · ATC C09DA07
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- HYDROCHLOORTHIAZIDE + TELMISARTAN
- Manufacturer
- Sandoz B.V.
- Country
- Netherlands (NL)
- ATC code
- C09DA07
- ATC class
- Telmisartan und Diuretika
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id111955
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for telmisartan und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Telmisartan und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09DA07
Telmisartan und diuretika, as other registers publish it.
- CanadaACH-TELMISARTAN HCTZACCORD HEALTHCARE INC
- CanadaACH-TELMISARTAN HCTZACCORD HEALTHCARE INC
- FinlandActelsar HctActavis Group PTC ehf
- FinlandActelsar HctActavis Group PTC ehf
- FinlandActelsar HctActavis Group PTC ehf
- IcelandActelsar HCTActavis Group PTC ehf.
- IcelandActelsar HCTActavis Group PTC ehf.
- NorwayActelsar HCTActavis Group PTC ehf
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b762bc29-bc76-4ce9-b863-c05a2875bc95 GET /v1/drugs/b762bc29-bc76-4ce9-b863-c05a2875bc95?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Omhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h111955_smpc.pdf",
"strength": null,
"atc_label": "Telmisartan And Diuretics",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg111955",
"excipients": [
"CITROENZUUR 1-WATER (E 330)",
"CROSPOVIDON (E 1202)",
"LACTOSE 0-WATER",
"LACTOSE 1-WATER",
"MACROGOL",
"MAGNESIUMSTEARAAT (E 470b)",
"MEGLUMINE",
"NATRIUMHYDROXIDE (E 524)",
"POLYVINYLALCOHOL (E 1203)",
"POVIDON K 25 (E 1201)",
"POVIDON K 30 (E 1201)",
"SILICIUMDIOXIDE (E 551)"
],
"substances": [
"HYDROCHLOORTHIAZIDE",
"TELMISARTAN"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h111955.pdf",
"authorised_at": "2013/11/05",
"procedure_number": "NL/H/2603/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "111955",
"additional_monitoring": "N"
}See everything about telmisartan und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.